- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07670208
Physical Activity Promoting Active Aging
Physical Activity Promoting Active Aging: An Exploration of Intrinsic Mechanisms and Practical Pathways
This project aims to explore the effects and underlying mechanisms of physical activity in promoting active aging among older adults. The researchers conducted two rounds of progressive randomized controlled intervention trials to verify the effects and mechanisms of a multimodal physical activity intervention on active aging from two dimensions: intervention structure and participation mode.
In Study 1, with a 12-week intervention period, participants were randomly assigned to three groups: a Tai Chi exercise group, a multimodal exercise group, and a daily activity control group. By comparing between-group differences, the study evaluated the effects of different exercise modalities on physical function and subjective active aging.
In Study 2, also with a 12-week intervention period, participants were randomly assigned to two multimodal exercise groups differing in participation mode: an in-person group-based format versus an online individual format. This study examined the moderating effects of different participation modes on both objective and subjective active aging outcomes, while keeping the multimodal physical activity intervention content identical.
Studie Overzicht
Toestand
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Department of Sports Science, College of Education, Zhejiang University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Aged 60 years or above;
Capable of engaging in regular physical activities and comprehending basic testing procedures and instructions.
Exclusion Criteria:
- Severe cardiac, pulmonary, or musculoskeletal disorders;
History of neurological or psychiatric conditions that may impair cognitive function (e.g., stroke, Parkinson's disease, Alzheimer's disease, major depressive disorder, etc.);
Missing three or more scheduled intervention sessions during the study period, or requesting discontinuation of participation.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Controlegroep
|
|
|
Experimenteel: Multicomponent oefengroep
|
Tai Chi, Baduanjin, strength, balance, and flexibility exercises
|
|
Experimenteel: Mind-body exercise group
|
Tai Chi, Yoga, and Baduanjin
|
|
Experimenteel: Online-based multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered via live online streaming and video watching)
|
|
Experimenteel: In-person multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered in an in-person group format)
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Active aging
Tijdsspanne: week0, week6, week12
|
It was measured using the Active Aging Questionnaire.
|
week0, week6, week12
|
|
General self-efficacy
Tijdsspanne: week0, week6, week12
|
It was measured using the General Self-Efficacy Scale.
|
week0, week6, week12
|
|
Cognitive function
Tijdsspanne: week0, week6, week12
|
Cognitive function was measured using the cognitive subscale of the LEIPAD questionnaire
|
week0, week6, week12
|
|
Cognitive function assessed by the Montreal Cognitive Assessment (MOCA)
Tijdsspanne: week0, week6, week12
|
Cognitive function was measured using the Montreal Cognitive Assessment (MOCA).
|
week0, week6, week12
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Height
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
Weight
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
Body fat percentage
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
Vital capacity test
Tijdsspanne: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
2-minute high-knee marching in place
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
Handgrip strength
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
Sit and reach test
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
|
|
30-second chair stand test
Tijdsspanne: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
One-legged stance with eyes closed tesr
Tijdsspanne: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
Choice reaction time
Tijdsspanne: week0, week6, week12
|
week0, week6, week12
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- ZJU-SSEC/2025/No.6
- 23NDJC001Z (Ander subsidie-/financieringsnummer: Key Program of Philosophy and Social Sciences Planning of Zhejiang Province)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .